Advertisement
Screener

CRONOS GROUP INC. (CRON) Deferred Income Tax Liabilities, Net

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Deferred Income Tax Liabilities, Net

CRONOS GROUP INC. (CRON) had Deferred Income Tax Liabilities, Net of $4.92 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent

us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-06

  • 2026-06-30: Deferred Income Tax Liabilities, Net $4.92M.
  • 2026-03-31: Deferred Income Tax Liabilities, Net $3.98M.
  • 2025-12-31: Deferred Income Tax Liabilities, Net $4.09M.
  • 2025-09-30: Deferred Income Tax Liabilities, Net $3.43M.
Period endDeferred Income Tax Liabilities, NetDeferred Income Tax Liabilities, Net as first filed
2026-06-30$4.92M
10-Q · filed 2026-08-06
2026-03-31$3.98M
10-Q · filed 2026-05-11
2025-12-31$4.09M
10-Q · filed 2026-08-06
2025-09-30$3.43M
10-Q · filed 2025-11-06
2025-06-30$5.54M
10-Q · filed 2025-08-07
2025-03-31$4.56M
10-Q · filed 2025-05-08
2024-12-31$3.56M
10-K · filed 2026-02-26
2024-09-30$11.14M
10-Q · filed 2024-11-12
2023-12-31$181.00K
10-K · filed 2025-02-27
$0.00
10-Q · filed 2024-11-12
2023-06-30$675.00K
10-Q · filed 2023-08-08
2023-03-31$378.00K
10-Q · filed 2023-05-09
2022-12-31$0.00
10-Q · filed 2023-08-08
2022-09-30$1.92M
10-Q · filed 2022-11-07
2022-06-30$46.00K
10-Q · filed 2022-08-09
2022-03-31$396.00K
10-Q · filed 2022-05-10
2021-12-31$81.00K
10-K · filed 2023-02-28
2020-12-31$0.00
10-K · filed 2022-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87